
Amwell, a healthcare technology company, granted restricted stock units (RSUs) covering 6,679 shares to two new non-executive employees as an inducement to join the company. The RSUs will vest 25% after one year and the remaining 75% quarterly over the next three years, contingent on continued employment. This grant was approved under Amwell's 2024 Inducement Plan and complies with NYSE rules. The move aims to attract talent to support Amwell's growth in technology-enabled healthcare services.